BONJESTA 20 mg/1
doxylamine succinate and pyridoxine hydrochloride · TABLET, EXTENDED RELEASE · Duchesnay USA, Inc.
BONJESTA is a tablet, extended release containing doxylamine succinate and pyridoxine hydrochloride at 20 mg/1, taken oral. Manufactured by Duchesnay USA, Inc..
Key Facts
- Brand Name
- BONJESTA
- Generic Name
- doxylamine succinate and pyridoxine hydrochloride
- NDC Code (Product)
55494-120- Manufacturer
- Duchesnay USA, Inc.
- Strength
- 20 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA209661
- Marketing Start
- 02/19/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is BONJESTA used for?
BONJESTA contains doxylamine succinate and pyridoxine hydrochloride. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is BONJESTA a controlled substance?
BONJESTA is not classified as a controlled substance by the DEA.
What is the generic name for BONJESTA?
The generic name for BONJESTA is doxylamine succinate and pyridoxine hydrochloride. There are 8 other brand versions of doxylamine succinate and pyridoxine hydrochloride.
What is the NDC code for BONJESTA 20 mg/1?
The NDC (National Drug Code) for BONJESTA 20 mg/1 is 55494-120, listed by Duchesnay USA, Inc..
Other Doxylamine Brands
See all →- Doxylamine succinate and Pyridoxine hydrochloride10 mg/169452-206
- Doxylamine Succinate and Pyridoxine Hydrochloride10 mg/10378-4615
- Doxylamine Succinate and Pyridoxine Hydrochloride10 mg/163629-2184
- Doxylamine succinate and pyridoxine hydrochloride10 mg/10591-2132
- Doxylamine Succinate and Pyridoxine Hydrochloride10 mg/149884-186
- Doxylamine Succinate and Pyridoxine Hydrochloride10 mg/172162-1485
- DICLEGIS10 mg/155494-100
- Doxylamine succinate and pyridoxine hydrochloride10 mg/170505-100
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)